EdgarLookup

V F CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that V F CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-9%
Profit Margin
Net income ÷ revenue
-2%
Return on Assets
Net income ÷ assets
5.3x
Debt-to-Equity
Total liabilities ÷ equity
-33.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2020 Mar 28, 2020 $2.10B May 27, 2020
FY2020 Dec 28, 2019 $3.16B May 27, 2020
FY2020 Sep 28, 2019 $3.18B May 27, 2020
FY2020 Jun 29, 2019 $2.05B May 27, 2020
FY2020 Mar 30, 2019 $2.36B May 27, 2020
FY2020 Dec 29, 2018 $2.98B May 27, 2020
FY2020 Sep 29, 2018 $3.00B May 27, 2020
FY2020 Jun 30, 2018 $1.92B May 27, 2020
FY2020 Mar 31, 2018 $2.18B May 27, 2020
FY2019 Dec 30, 2017 $3.65B May 24, 2019

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $9.50B May 22, 2025
FY2025 Mar 30, 2024 $9.92B May 22, 2025
FY2025 Apr 1, 2023 $11.09B May 22, 2025
FY2024 Apr 2, 2022 $11.84B May 23, 2024
FY2023 Apr 3, 2021 $9.24B May 25, 2023
FY2022 Mar 28, 2020 $10.49B May 26, 2022
FY2021 Mar 30, 2019 $10.27B May 27, 2021
FY2020 Mar 31, 2018 $2.18B May 27, 2020
FY2020 Dec 30, 2017 $8.39B May 27, 2020
FY2019 Dec 31, 2016 $11.03B May 24, 2019

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 30, 2017 $11.74B Feb 28, 2018
FY2017 Dec 31, 2016 $10.96B Feb 28, 2018
FY2017 Jan 2, 2016 $10.92B Feb 28, 2018
FY2016 Jan 3, 2015 $11.76B Mar 1, 2017
FY2015 Dec 28, 2013 $11.30B Mar 2, 2016
FY2014 Dec 29, 2012 $10.77B Mar 3, 2015
FY2013 Dec 31, 2011 $9.37B Feb 26, 2014
FY2012 Jan 1, 2011 $7.62B Feb 27, 2013
FY2011 Jan 2, 2010 $7.14B Feb 29, 2012
FY2010 Jan 3, 2009 $7.56B Mar 2, 2011

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 ($189.72M) May 22, 2025
FY2025 Mar 30, 2024 ($968.88M) May 22, 2025
FY2025 Apr 1, 2023 $118.58M May 22, 2025
FY2024 Apr 2, 2022 $1.39B May 23, 2024
FY2023 Apr 3, 2021 $407.87M May 25, 2023
FY2020 Mar 28, 2020 ($483.78M) May 27, 2020
FY2020 Dec 28, 2019 $465.00M May 27, 2020
FY2020 Sep 28, 2019 $649.00M May 27, 2020
FY2020 Jun 29, 2019 $49.22M May 27, 2020
FY2020 Mar 30, 2019 $128.80M May 27, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $303.77M May 22, 2025
FY2025 Mar 30, 2024 ($143.94M) May 22, 2025
FY2025 Apr 1, 2023 $998.74M May 22, 2025
FY2024 Apr 2, 2022 $1.63B May 23, 2024
FY2023 Apr 3, 2021 $607.63M May 25, 2023
FY2020 Mar 28, 2020 ($256.76M) May 27, 2020
FY2020 Dec 28, 2019 $540.04M May 27, 2020
FY2020 Sep 28, 2019 $548.56M May 27, 2020
FY2020 Jun 29, 2019 $95.97M May 27, 2020
FY2020 Mar 30, 2019 $126.36M May 27, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $4.69B May 22, 2025
FY2025 Mar 30, 2024 $4.75B May 22, 2025
FY2025 Apr 1, 2023 $4.80B May 22, 2025
FY2024 Apr 2, 2022 $4.82B May 23, 2024
FY2023 Apr 3, 2021 $4.24B May 25, 2023
FY2022 Mar 28, 2020 $4.55B May 26, 2022
FY2021 Mar 30, 2019 $4.42B May 27, 2021
FY2020 Mar 31, 2018 $1.03B May 27, 2020
FY2020 Dec 30, 2017 $3.66B May 27, 2020
FY2019 Dec 31, 2016 $3.90B May 24, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $465.24M May 22, 2025
FY2025 Mar 30, 2024 $1.01B May 22, 2025
FY2025 Apr 1, 2023 ($655.80M) May 22, 2025
FY2024 Apr 2, 2022 $864.29M May 23, 2024
FY2023 Apr 3, 2021 $1.31B May 25, 2023
FY2022 Mar 28, 2020 $874.53M May 26, 2022
FY2021 Mar 30, 2019 $1.66B May 27, 2021
FY2020 Mar 31, 2018 ($243.22M) May 27, 2020
FY2020 Dec 30, 2017 $1.47B May 27, 2020
FY2019 Dec 31, 2016 $1.48B May 24, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $9.38B May 22, 2025
FY2025 Mar 30, 2024 $11.61B May 22, 2025
FY2025 Apr 1, 2023 $13.99B May 22, 2025
FY2023 Apr 2, 2022 $13.34B May 25, 2023
FY2022 Apr 3, 2021 $13.75B May 26, 2022
FY2021 Mar 28, 2020 $11.13B May 27, 2021
FY2020 Mar 30, 2019 $10.36B May 27, 2020
FY2019 Mar 31, 2018 $10.31B May 24, 2019
FY2019 Dec 30, 2017 $9.96B May 24, 2019
FY2017 Dec 31, 2016 $9.74B Feb 28, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $7.89B May 22, 2025
FY2025 Mar 30, 2024 $9.95B May 22, 2025
FY2024 Apr 1, 2023 $11.08B May 23, 2024
FY2023 Apr 2, 2022 $9.81B May 25, 2023
FY2022 Apr 3, 2021 $10.70B May 26, 2022
FY2021 Mar 28, 2020 $7.78B May 27, 2021
FY2020 Mar 30, 2019 $6.06B May 27, 2020
FY2019 Mar 31, 2018 $6.62B May 24, 2019
FY2019 Dec 30, 2017 $6.24B May 24, 2019
FY2017 Dec 31, 2016 $4.80B Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $1.49B May 22, 2025
FY2025 Mar 30, 2024 $1.66B May 22, 2025
FY2025 Apr 1, 2023 $2.91B May 22, 2025
FY2025 Apr 2, 2022 $3.53B May 22, 2025
FY2024 Apr 3, 2021 $3.06B May 23, 2024
FY2023 Mar 28, 2020 $3.36B May 25, 2023
FY2022 Mar 30, 2019 $4.30B May 26, 2022
FY2021 Mar 31, 2018 $3.69B May 27, 2021
FY2020 Dec 30, 2017 $3.72B May 27, 2020
FY2020 Dec 31, 2016 $4.94B May 27, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $603.39M May 22, 2025
FY2025 Mar 30, 2024 $645.36M May 22, 2025
FY2025 Apr 1, 2023 $1.16B May 22, 2025
FY2024 Apr 2, 2022 $2.39B May 23, 2024
FY2023 Apr 3, 2021 $2.43B May 25, 2023
FY2022 Mar 28, 2020 $1.16B May 26, 2022
FY2021 Mar 30, 2019 $1.49B May 27, 2021
FY2020 Mar 31, 2018 $1.42B May 27, 2020
FY2019 Dec 30, 2017 $1.69B May 24, 2019
FY2019 Dec 31, 2016 $1.55B May 24, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 ($1.17B) May 22, 2025
FY2025 Mar 30, 2024 ($974.58M) May 22, 2025
FY2024 Apr 1, 2023 $57.09M May 23, 2024
FY2023 Apr 2, 2022 $443.48M May 25, 2023
FY2022 Apr 3, 2021 $189.53M May 26, 2022
FY2021 Mar 28, 2020 $7.31M May 27, 2021
FY2020 Mar 30, 2019 $1.18B May 27, 2020
FY2019 Mar 31, 2018 $846.12M May 24, 2019
FY2019 Dec 30, 2017 $1.02B May 24, 2019
FY2017 Dec 31, 2016 $2.55B Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $429.38M May 22, 2025
FY2025 Mar 30, 2024 $656.38M May 22, 2025
FY2025 Apr 1, 2023 $799.44M May 22, 2025
FY2024 Apr 2, 2022 $1.28B May 23, 2024
FY2023 Apr 3, 2021 $815.75M May 25, 2023
FY2022 Mar 28, 2020 $1.37B May 26, 2022
FY2021 Mar 30, 2019 $402.23M May 27, 2021
FY2020 Mar 31, 2018 $523.31M May 27, 2020
FY2020 Dec 30, 2017 $434.15M May 27, 2020
FY2019 Dec 31, 2016 $1.22B May 24, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $3.95B May 22, 2025
FY2024 Mar 30, 2024 $5.69B May 23, 2024
FY2023 Apr 1, 2023 $6.62B May 25, 2023
FY2022 Apr 2, 2022 $5.07B May 26, 2022
FY2021 Apr 3, 2021 $5.69B May 27, 2021
FY2020 Mar 28, 2020 $2.59B May 27, 2020
FY2019 Mar 30, 2019 $2.09B May 24, 2019
FY2017 Dec 30, 2017 $2.15B Feb 28, 2018
FY2016 Dec 31, 2016 $2.28B Mar 1, 2017
FY2015 Jan 2, 2016 $1.39B Mar 2, 2016

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 0 May 22, 2025
FY2025 Mar 30, 2024 (2) May 22, 2025
FY2025 Apr 1, 2023 0 May 22, 2025
FY2024 Apr 2, 2022 3 May 23, 2024
FY2023 Apr 3, 2021 1 May 25, 2023
FY2020 Mar 28, 2020 (1) May 27, 2020
FY2020 Dec 28, 2019 1 May 27, 2020
FY2020 Sep 28, 2019 1 May 27, 2020
FY2020 Jun 29, 2019 0 May 27, 2020
FY2020 Mar 30, 2019 0 May 27, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 0 May 22, 2025
FY2025 Mar 30, 2024 (2) May 22, 2025
FY2025 Apr 1, 2023 0 May 22, 2025
FY2024 Apr 2, 2022 3 May 23, 2024
FY2023 Apr 3, 2021 1 May 25, 2023
FY2020 Mar 28, 2020 (1) May 27, 2020
FY2020 Dec 28, 2019 1 May 27, 2020
FY2020 Sep 28, 2019 1 May 27, 2020
FY2020 Jun 29, 2019 0 May 27, 2020
FY2020 Mar 30, 2019 0 May 27, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 389.70M May 22, 2025
FY2025 Mar 30, 2024 388.84M May 22, 2025
FY2024 Apr 1, 2023 388.67M May 23, 2024
FY2023 Apr 2, 2022 388.30M May 25, 2023
FY2022 Apr 3, 2021 391.94M May 26, 2022
FY2021 Mar 28, 2020 388.81M May 27, 2021
FY2020 Mar 30, 2019 396.82M May 27, 2020
FY2019 Mar 31, 2018 394.31M May 24, 2019
FY2019 Dec 30, 2017 395.82M May 24, 2019
FY2017 Dec 31, 2016 414.01M Feb 28, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Mar 29, 2025 $140.17M May 22, 2025
FY2025 Mar 30, 2024 $303.14M May 22, 2025
FY2025 Apr 1, 2023 $702.85M May 22, 2025
FY2024 Apr 2, 2022 $773.21M May 23, 2024
FY2023 Apr 3, 2021 $756.78M May 25, 2023
FY2022 Mar 28, 2020 $748.66M May 26, 2022
FY2021 Mar 30, 2019 $767.06M May 27, 2021
FY2020 Mar 31, 2018 $181.37M May 27, 2020
FY2020 Dec 30, 2017 $684.68M May 27, 2020
FY2019 Dec 31, 2016 $635.99M May 24, 2019